Edition:
United States

People: United Therapeutics Corp (UTHR.OQ)

UTHR.OQ on NASDAQ Stock Exchange Global Select Market

103.60USD
25 May 2018
Change (% chg)

$-1.13 (-1.08%)
Prev Close
$104.73
Open
$104.82
Day's High
$107.06
Day's Low
$103.58
Volume
76,897
Avg. Vol
176,037
52-wk High
$152.55
52-wk Low
$100.64

Mahon, Paul 

Mr. Paul A. Mahon, J.D. is Executive Vice President, General Counsel, Corporate Secretary of the Company. He has served as General Counsel and Corporate Secretary of United Therapeutics since its inception in 1996. In June 2001, Mr. Mahon joined United Therapeutics full-time as Senior Vice President, General Counsel and Corporate Secretary. In November 2003, Mr. Mahon was promoted to Executive Vice President, General Counsel and Corporate Secretary. Prior to June 2001, he served United Therapeutics, beginning with its formation in 1996, in his capacity as principal and managing partner of a law firm specializing in technology and media law.

Basic Compensation

Total Annual Compensation, USD 1,356,490
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 6,271,710
Fiscal Year Total, USD 7,628,200

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Martine Rothblatt

15,424,300

Michael Benkowitz

5,351,160

Christopher Patusky

528,183

James Edgemond

4,109,450

Paul Mahon

7,628,200

Raymond Dwek

422,782
As Of  30 Dec 2016